Flumine Pharmaceuticals Private Limited
About Flumine Pharmaceuticals Private Limited
Data last updated:
Flumine Pharmaceuticals Private Limited is a private limited company based in Ropar, Punjab, India. It operates in the service-based operations segment of the business services sector. It was incorporated on 09 April 2018 and has been in existence for over 8 years.
The company is registered with the Registrar of Companies (ROC), Chandigarh, under CIN U74999PB2018PTC047730. Its GSTIN is 02AADCF3660R1ZF (Himachal Pradesh).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Shweta Patware and Harpreet Kaur.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at #3354/2D Street No. 03A Adarsh Nagar Ropar, Punjab, India – 140001.
As per the financials filed for FY 2024, the company reported a revenue of ₹2.79 Lakh, a decline of 89% compared to the previous year. For the same year it recorded a net loss of ₹1.92 Lakh (net margin -68.8%) and EBITDA of -₹1.86 Lakh (EBITDA margin -66.7%). Revenue has declined at a compounded annual rate (CAGR) of 28% over three years and 12% over five years.
Company details
Contact details
Flumine Pharmaceuticals Private Limited's registered office is in Ropar, Punjab. Its e-mail address is in the company report.
- Email
- Registered Address#3354/2D Street No. 03A Adarsh Nagar Ropar, Punjab, India – 140001
- IndustryBusiness Services, Other Services, Miscellaneous Business Activities
To see the full contact details of Flumine Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Flumine Pharmaceuticals Private Limited
FY 2025 filings availableFlumine Pharmaceuticals Private Limited reported revenue of ₹2.79 Lakh (down 89% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue has declined at a compounded annual rate (CAGR) of 12% over five years, including a 89% fall in the latest year. EBITDA fell 604% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹1.86 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹1.92 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -66.7% | ||||
| Net Profit Margin | -68.8% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Flumine Pharmaceuticals Private Limited, buy the company report.
Board of directors of Flumine Pharmaceuticals Private Limited
Flumine Pharmaceuticals has 2 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Shweta Patware | Director | 19 Oct 2020 | 6 Years 0 Months | Current |
| Harpreet Kaur | Director | 19 Oct 2020 | 6 Years 0 Months | Current |
Peer comparison
Flumine Pharmaceuticals Private Limited is compared with the 10 companies closest to it by revenue in the Pharma industry (Pharmaceuticals), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Roldac Pharmaceuticals Private Limited | ₹2.81 Lakh (FY 2023) | -64.0% | Dehradun, Uttarakhand, India | |||
| Centriole Pharmaceuticals Private Limited | ₹2.81 Lakh (FY 2022) | Pune, Maharashtra, India | ||||
| Million Health Pharmaceuticals Private Limited | ₹2.8 Lakh (FY 2021) | Mumbai, Maharashtra, India | ||||
| Melody Pharmaceuticals Private Limited | ₹2.8 Lakh (FY 2023) | 85.0% | Naveen Nagar, Uttar Pradesh, India | |||
| Adventure Pharmaceuticals Private Limited | ₹2.8 Lakh (FY 2025) | -48.0% | Patna, Bihar, India | |||
| Flumine Pharmaceuticals Private Limitedthis company | ₹2.79 Lakh (FY 2024) | -₹1.92 Lakh | -68.8% | -89.0% | Ropar, Punjab, India | |
| Lopa Pharmaceuticals Private Limited | ₹2.78 Lakh (FY 2020) | Delhi, India | ||||
| Chemixal Pharmaceuticals Private Limited | ₹2.78 Lakh (FY 2020) | 264.0% | Kota, Rajasthan, India | |||
| Pharmavio Pharmaceuticals (OPC) Private Limited | ₹2.76 Lakh (FY 2025) | 661.0% | Zeerapur, Madhya Pradesh, India | |||
| Invasa Pharmaceuticals Private Limited | ₹2.76 Lakh (FY 2024) | 5.0% | Bhopal, Madhya Pradesh, India | |||
| Veerja Pharmaceuticals Private Limited | ₹2.76 Lakh (FY 2025) | 1.0% | Delhi, India |
To see the full peer comparison of Flumine Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Flumine Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Flumine Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Flumine Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 02AADCF3660R1ZF | Himachal Pradesh | Active | 28 Apr 2018 |
To see the full GST registrations and return filing status of Flumine Pharmaceuticals Private Limited, buy the company report.
Recent activity
Flumine Pharmaceuticals Private Limited has 5 board changes on record since 2020: 2 appointments and 3 cessations. The latest: Anand Band ceased to be Director on 15 Nov 2022.
Frequently asked questions
Flumine Pharmaceuticals is an active private limited company based in Ropar, Punjab, India. The company works in other services, within the business services industry. It was incorporated on 09 April 2018 (8+ years old) and is registered under CIN U74999PB2018PTC047730.
Flumine Pharmaceuticals has 2 current directors:
- Shweta Patware - Director
- Harpreet Kaur - Director
The latest financial statements of Flumine Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2019 are in the company report.
The GSTIN of Flumine Pharmaceuticals is 02AADCF3660R1ZF, registered in Himachal Pradesh.
The CIN (Corporate Identification Number) of Flumine Pharmaceuticals is U74999PB2018PTC047730. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Flumine Pharmaceuticals was incorporated on 09 April 2018, making it 8+ years old. It is registered with the Registrar of Companies, Chandigarh.
The peers of Flumine Pharmaceuticals by revenue are Roldac Pharmaceuticals Private Limited, Centriole Pharmaceuticals Private Limited, Million Health Pharmaceuticals Private Limited, Melody Pharmaceuticals Private Limited, Adventure Pharmaceuticals Private Limited and 5 more, all in the Pharma industry (Pharmaceuticals).
Anand Band ceased to be Director on 15 Nov 2022. Gurpreet Singh ceased to be Director on 15 Nov 2022. Rupinder Kaur ceased to be Director on 23 Apr 2021. Flumine Pharmaceuticals has 5 board changes on record in total.
The registered office of Flumine Pharmaceuticals is at #33542D Street No. 03A Adarsh Nagar Ropar, Punjab, India – 140001.
Flumine Pharmaceuticals operates in the business services industry, in the other services segment.
Flumine Pharmaceuticals can be reached at its registered office: #33542D Street No. 03A Adarsh Nagar Ropar, Punjab, India – 140001.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
